94 related articles for article (PubMed ID: 7789043)
21. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
Martin W; Furchgott RF; Villani GM; Jothianandan D
J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
[TBL] [Abstract][Full Text] [Related]
22. Time-dependent enhancement of xylazine-induced, alpha-2 adrenoceptor-mediated vasoconstriction in isolated and perfused canine pulmonary veins.
Haniuda M; Itoh N; Chiba S
J Pharmacol Exp Ther; 1989 Apr; 249(1):340-7. PubMed ID: 2565395
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate.
Sekkarie MA; Egan BM; Neubig RR; Supiano MA
Clin Pharmacol Ther; 1990 Nov; 48(5):537-43. PubMed ID: 2171846
[TBL] [Abstract][Full Text] [Related]
24. Exogenous NO administration and alpha-adrenergic vasoconstriction in human limbs.
Rosenmeier JB; Fritzlar SJ; Dinenno FA; Joyner MJ
J Appl Physiol (1985); 2003 Dec; 95(6):2370-4. PubMed ID: 12923119
[TBL] [Abstract][Full Text] [Related]
25. Alpha1A- and alpha1D-adrenoceptors are the major functional subtypes of renal alpha1-adrenoceptors in streptozotocin-induced diabetic and normal Sprague-Dawley rats.
; Sattar MA; Abdullah NA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Jan; 28(1):1-10. PubMed ID: 18257746
[TBL] [Abstract][Full Text] [Related]
26. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
[TBL] [Abstract][Full Text] [Related]
27. alpha1- and alpha2-adrenergic vasoconstriction is blunted in contracting human muscle.
Rosenmeier JB; Dinenno FA; Fritzlar SJ; Joyner MJ
J Physiol; 2003 Mar; 547(Pt 3):971-6. PubMed ID: 12588902
[TBL] [Abstract][Full Text] [Related]
28. Intracellular alkalinization augments alpha(1)-adrenoceptor-mediated vasoconstriction by promotion of Ca(2+) entry through the non-L-type Ca(2+) channels.
Wakabayashi I; Masui H; Groschner K
Eur J Pharmacol; 2001 Oct; 428(2):251-9. PubMed ID: 11675043
[TBL] [Abstract][Full Text] [Related]
29. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
[TBL] [Abstract][Full Text] [Related]
30. Ambulatory blood pressure monitoring and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus.
Cohen CN; Albanesi FM; Gonçalves MF; Gomes MB
Arq Bras Cardiol; 2000 Sep; 75(3):195-204. PubMed ID: 11018805
[TBL] [Abstract][Full Text] [Related]
31. Ageing and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men.
Smith EG; Voyles WF; Kirby BS; Markwald RR; Dinenno FA
J Physiol; 2007 Jul; 582(Pt 1):63-71. PubMed ID: 17463044
[TBL] [Abstract][Full Text] [Related]
32. Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase.
Jinsi A; Deth RC
Eur J Pharmacol; 1995 Apr; 277(1):29-34. PubMed ID: 7635170
[TBL] [Abstract][Full Text] [Related]
33. Functional subtypes of renal alpha1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension.
Armenia A; Sattar MA; Abdullah NA; Khan MA; Johns EJ
Acta Pharmacol Sin; 2008 May; 29(5):564-72. PubMed ID: 18430364
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of arteriolar alpha 2-adrenoceptor sensitivity during endotoxemia.
Baker CH; Sutton ET; Price JM; Ortiz-Tweed M; Nessellroth S
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2171-8. PubMed ID: 7810716
[TBL] [Abstract][Full Text] [Related]
35. Evidence against alpha-adrenoceptors mediating relaxation in rat thoracic aortae: alpha-agonists relaxation depends on interaction with alpha-adrenoceptors.
Castillo EF; Ortíz CS; López RM; Ruíz A; Vélez JM; Castillo C
Fundam Clin Pharmacol; 2006 Aug; 20(4):339-49. PubMed ID: 16867017
[TBL] [Abstract][Full Text] [Related]
36. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
Mogensen CE
Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882
[TBL] [Abstract][Full Text] [Related]
37. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
Smith KM; Macmillan JB; McGrath JC
Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of the alpha-adrenoceptor agonists noradrenaline, phenylephrine and clonidine in the human saphenous vein in vivo and in vitro.
Sjöberg T; Norgren L; Andersson KE; Steen S
Acta Physiol Scand; 1989 Jul; 136(3):463-71. PubMed ID: 2568732
[TBL] [Abstract][Full Text] [Related]
39. Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion.
Topper E; Gertner J; Amiel S; Press M; Genel M; Tamborlane WV
Pediatr Res; 1985 Jun; 19(6):534-6. PubMed ID: 2989759
[TBL] [Abstract][Full Text] [Related]
40. Regulation of venous alpha-adrenergic responses in older humans.
Supiano MA; Hogikyan RV; Stoltz AM; Orstan N; Halter JB
Am J Physiol; 1991 Apr; 260(4 Pt 1):E599-607. PubMed ID: 1850202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
